Implementación del modelo Leer para aprender en un contexto plurilingüe

Este trabajo describe el proceso de formación y colaboración desarrollado entre un centro de primaria del País Vasco y un grupo de investigadoras de la Universidad Mondragón (País Vasco). El objeto de colaboración es el diseño e implementación de un proyecto para reforzar los procesos de lectura y de escritura en dos grupos de 6º de primaria en tres áreas: Lengua Castellana, Euskera y Science (Conocimiento del medio), impartidas en tres lenguas diferentes: español, euskera e inglés. La base teórica elegida para desarrollar cada secuencia didáctica es la pedagogía de los géneros (Genre Pedagogy), concretada en la metodología Reading to Learn desarrollada por David Rose.This paper describes the process of training and collaboration between a primary school in the Basque Country and a group of researchers at Mondragon University in the same region. The purpose of the work together is to design and put into practice a project to support reading and writing in two groups of year 6 primary pupils in three curriculum areas: Spanish Language, Basque Language and Science (or Learning about the world around us) taught in three different languages: Spanish, Basque and English. The theoretical foundation chosen to design the didactic units is that of Genre Pedagogy, specifically the method of Reading to Learn developed by David Rose

A method for the complete analysis of NORM building materials by γ-ray spectrometry using HPGe detectors

[EN] A methodology including software tools for analysing NORM building materials and residues by low-level gamma-ray spectrometry has been developed. It comprises deconvolution of gamma-ray spectra using the software GALEA with focus on the natural radionuclides and Monte Carlo simulations for efficiency and true coincidence summing corrections. The methodology has been tested on a range of building materials and validated against reference materials

Precise 210Pb determination with high-efficiency gamma spectrometry for dating of marine sedimentary cores

[EN]In order to establish the chronology of deep-sea sediments from high-resolution 210Pb-dating, the determination of 210Pb and 226Ra activity concentrations needs to be improved. Gamma spectrometry allows determining simultaneously both radionuclides. However, spectrum background is still an issue to obtain high sensitivity. Four deep-sea sediment cores were dated using Mazinger, a gamma spectrometer with high-efficiency and very low-background, and the Constant Rate and Supply model was applied to obtain recent age

Dating the Anthropocene in deep-sea sediments: a gamma spectrometric approach

1 poster presented at the International meeting of Sedimentology 2017 in Toulouse, France, from October 10th to 13thUtilizando muestras de sedimentos superficiales obtenidas durante la campaña OVIDE/BOCATS 2016 y una innovadora técnica para establecer cronologías absolutas, se ha obtenido una primera estimación cuantitativa de los flujos de carbono hacia sedimentos profundos en la cuenca subpolar de Irminger. La geocronología basada en espectrometría gamma de alta resolución y bajo fondo con dos detectores simultáneos de germanio hiper-puro (HPGe) es una técnica suficientemente precisa y sensible como para datar sedimentos pelágicos profundos. El papel cuantitativo del Irminger como sumidero de carbono durante el Antropoceno se evaluó combinando una cronología basada en el radionúclido natural 210Pb junto a análisis sedimentológicos y de composición elemental. La tasa media de sedimentación para el canal central del Irminger es de 0.83±0.14 mm·yr-1. Los cálculos de flujos de carbono concluyen que durante el Antropoceno 32±14 g·Cinorg·m-2·año-1 y 4.5±3 g·Corg·m-2·año-1 sedimentan en la cuenca del Irminger, suponiendo un considerable sumidero de carbono en el área cuantificado en más de 22 Tg-C·año−1N

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.

Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may suffer from this complication. CDA is a complex trait with a polygenic component that is mainly unidentified. We propose that levels of intermediate molecular phenotypes (IMPs) in the myocardium associated with histopathological damage could explain CDA susceptibility, so variants of genes encoding these IMPs could identify patients susceptible to this complication. Thus, a genetically heterogeneous cohort of mice (n = 165) generated by backcrossing were treated with doxorubicin and docetaxel. We quantified heart fibrosis using an Ariol slide scanner and intramyocardial levels of IMPs using multiplex bead arrays and QPCR. We identified quantitative trait loci linked to IMPs (ipQTLs) and cdaQTLs via linkage analysis. In three cancer patient cohorts, CDA was quantified using echocardiography or Cardiac Magnetic Resonance. CDA behaves as a complex trait in the mouse cohort. IMP levels in the myocardium were associated with CDA. ipQTLs integrated into genetic models with cdaQTLs account for more CDA phenotypic variation than that explained by cda-QTLs alone. Allelic forms of genes encoding IMPs associated with CDA in mice, including AKT1, MAPK14, MAPK8, STAT3, CAS3, and TP53, are genetic determinants of CDA in patients. Two genetic risk scores for pediatric patients (n = 71) and women with breast cancer (n = 420) were generated using machine-learning Least Absolute Shrinkage and Selection Operator (LASSO) regression. Thus, IMPs associated with heart damage identify genetic markers of CDA risk, thereby allowing more personalized patient management.J.P.L.’s lab is sponsored by Grant PID2020-118527RB-I00 funded by MCIN/AEI/10.13039/ 501100011039; Grant PDC2021-121735-I00 funded by MCIN/AEI/10.13039/501100011039 and by the “European Union Next Generation EU/PRTR”, the Regional Government of Castile and León (CSI144P20). J.P.L. and P.L.S. are supported by the Carlos III Health Institute (PIE14/00066). AGN laboratory and human patients’ studies are supported by an ISCIII project grant (PI18/01242). The Human Genotyping unit is a member of CeGen, PRB3, and is supported by grant PT17/0019 of the PE I + D + i 2013–2016, funded by ISCIII and ERDF. SCLl is supported by MINECO/FEDER research grants (RTI2018-094130-B-100). CH was supported by the Department of Defense (DoD) BCRP, No. BC190820; and the National Cancer Institute (NCI) at the National Institutes of Health (NIH), No. R01CA184476. Lawrence Berkeley National Laboratory (LBNL) is a multi-program national laboratory operated by the University of California for the DOE under contract DE AC02-05CH11231. The Proteomics Unit belongs to ProteoRed, PRB3-ISCIII, supported by grant PT17/0019/0023 of the PE I + D +i, 2017–2020, funded by ISCIII and FEDER. RCC is funded by fellowships from the Spanish Regional Government of Castile and León. NGS is a recipient of an FPU fellowship (MINECO/FEDER). hiPSC-CM studies were funded in part by the “la Caixa” Banking Foundation under the project code HR18-00304 and a Severo Ochoa CNIC Intramural Project (Exp. 12-2016 IGP) to J.J.S

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections

IMPORTANCE The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these infections is critical, for which some neglected drugs may be an option. OBJECTIVE To determine whether fosfomycin is noninferior to ceftriaxone or meropenem in the targeted treatment of bacteremic urinary tract infections (bUTIs) due to MDR E coli. DESIGN, SETTING, AND PARTICIPANTS This multicenter, randomized, pragmatic, open clinical trial was conducted at 22 Spanish hospitals from June 2014 to December 2018. Eligible participants were adult patients with bacteremic urinary tract infections due to MDR E coli; 161 of 1578 screened patients were randomized and followed up for 60 days. Data were analyzed in May 2021. INTERVENTIONS Patients were randomized 1 to 1 to receive intravenous fosfomycin disodium at 4 g every 6 hours (70 participants) or a comparator (ceftriaxone or meropenem if resistant; 73 participants) with the option to switch to oral fosfomycin trometamol for the fosfomycin group or an active oral drug or pa renteral ertapenem for the comparator group after 4 days. MAIN OUTCOMES AND MEASURES The primary outcome was clinical and microbiological cure (CMC) 5 to 7 days after finalization of treatment; a noninferiority margin of 7% was considered. RESULTS Among 143 patients in the modified intention-to-treat population (median [IQR] age, 72 [62-81] years; 73 [51.0%] women), 48 of 70 patients (68.6%) treated with fosfomycin and 57 of 73 patients (78.1%) treated with comparators reached CMC (risk difference, -9.4 percentage points; 1-sided 95% CI, -21.5 to infinity percentage points; P = .10). While clinical or microbiological failure occurred among 10 patients (14.3%) treated with fosfomycin and 14 patients (19.7%) treated with comparators (risk difference, -5.4 percentage points; 1-sided 95% CI. -infinity to 4.9; percentage points; P = .19), an increased rate of adverse event-related discontinuations occurred with fosfomycin vs comparators (6 discontinuations [8.5%] vs 0 discontinuations; P = .006). In an exploratory analysis among a subset of 38 patients who underwent rectal colonization studies, patients treated with fosfomycin acquired a new ceftriaxone-resistant or meropenem-resistant gram-negative bacteria at a decreased rate compared with patients treated with comparators (0 of 21 patients vs 4 of 17 patients [23.5%]; 1-sided P = .01). CONCLUSIONS AND RELEVANCE This study found that fosfomycin did not demonstrate noninferiority to comparators as targeted treatment of bUTI from MDR E coli; this was due to an increased rate of adverse event-related discontinuations. This finding suggests that fosfomycin may be considered for selected patients with these infections

Museos y exposiciones en Madrid como oportunidad de trabajar conceptos-clave de las Ciencias Sociales con estudiantes Erasmus+ Incoming en colaboración con estudiantes UCM, asociaciones de estudiantes, oficina de relaciones internacionales y PDI

Proyecto de Innovación que pone en contacto los recursos museísticos y expositivos de Madrid con los estudiantes internacionales para trabajar conceptos-clave en las ciencias sociales, como vulnerabilidad y comunicació